Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up

[1]  K. Stockerl-Goldstein,et al.  Allogeneic Hematopoietic Cell Transplantation for Adult Patients With Acute Myeloid Leukemia , 2007 .

[2]  Q. Jiang,et al.  [A novel approach to HLA-mismatched transplantation]. , 2004, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

[3]  F. Ferrara,et al.  Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemia. , 2004, Haematologica.

[4]  N. Harris,et al.  The World Health Organization (WHO) classification of the myeloid neoplasms. , 2002, Blood.

[5]  M. Slovak,et al.  Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase. , 2002, Blood.

[6]  S. Fenu,et al.  Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. , 2002, Haematologica.

[7]  G. Ehninger,et al.  Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia , 2001, Bone Marrow Transplantation.

[8]  G. Vogelsang.  How I treat chronic graft-versus-host disease. , 2001, Blood.

[9]  M. Remberger,et al.  T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation. , 2001, Transplantation.

[10]  T. Lion,et al.  Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers , 2001, Leukemia.

[11]  J. Bennett,et al.  World Health Organization classification of the acute leukemias and myelodysplastic syndrome. , 2000, International journal of hematology.

[12]  J. Wachowiak,et al.  Molecular assessment of post-BMT chimerism using various biologic specimens and automated DNA sizing technology. , 2000, Journal of hematotherapy & stem cell research.

[13]  O. Ringdén,et al.  Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia , 2000, Bone Marrow Transplantation.

[14]  J. A. Murray.  Postgraduate Haematology (4th edn). , 1999 .

[15]  R. Herrmann,et al.  Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia , 1999, British journal of haematology.

[16]  R. Storb,et al.  Successful nonmyeloablative allogeneic hematopoietic stem cell transplant in an acute leukemia patient with chemotherapy-induced marrow aplasia and progressive pulmonary aspergillosis. , 1999, Blood.

[17]  R. Advani,et al.  Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar) , 1999 .

[18]  I. Buño,et al.  Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI). , 1998, Haematologica.

[19]  J. Whitlock,et al.  High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia , 1997, Leukemia.

[20]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[21]  M. Dimopoulos,et al.  Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation , 1994, American journal of hematology.

[22]  J. Mehta,et al.  Bone marrow transplantation for primary refractory acute leukaemia. , 1994, Bone marrow transplantation.

[23]  V. Heinemann,et al.  Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine. , 1993, Annals of hematology.

[24]  J. Niland,et al.  Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  S. Jagannath,et al.  A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  S. Jagannath,et al.  Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy , 1985, Cancer.

[27]  W. Wilmanns,et al.  [Allogeneic bone marrow transplantation in a patient with bone marrow aplasia]. , 1980, Der Internist.

[28]  L. Peters,et al.  AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN RELAPSED ADULT ACUTE LEUKÆMIA , 1979, The Lancet.

[29]  A. Zander,et al.  Autologous bone marrow transplantation in relapsed adult acute leukemia. , 1979, Experimental hematology.

[30]  A. Zander,et al.  Autologous bone-marrow transplantation in relapsed adult acute leukaemia. , 1979, Lancet.

[31]  A. Zander,et al.  AUTOLOGOUS BONE MARROW TRANSPLANTATION IN PATIENTS WITH ADULT ACUTE LEUKEMIA IN RELAPSE , 1978, Transplantation.